Wuhan Jetide Biotech Co., Ltd., established in September 2012 with a registered capital of RMB62.8 million, and headquartered in Wuhan Optics Valley Biomedical Park is a biomedical enterprise integrating R&D, production and sales, with three wholly-owned subsidiaries, which are Hubei Huntide Biotech Co., Ltd., Wuhan Jason Biotech Co., Ltd. and Guangzhou Kangqiao Hanpu Pharmaceutical Co., Ltd.
We have two production bases, one located in Xintan Industrial Park, Wuhan Economic & Technological Development Zone, covering an area of 108 mu (72000m2), and another one in Yunpu Industrial Zone, Huangpu District, Guangzhou City. We’re committed to becoming the world’s first High-quality Development of Technologically Advanced Enterprise focusing on the industrialization of small molecule active peptides.
We have six main business sectors: new drugs and generic drugs, raw materials, pharmaceutical intermediates, raw materials for dietary supplements, raw materials for cosmetics, food and feed additives.
Dipeptides: L-Carnosine, Zinc Carnosine(polaprezinc), N(2)-L-Alanyl-L-Glutamine, Glycyl-L-Glutamine, Glycyl-L-Tyrosine, L-Alanyl-L-Tyrosine, derivatives of amino acids, SYN-AKE and other active peptides for cosmetics.
APIs: Boric acid, Borax and Ammonium chloride.
Pharmaceutical excipients: Carbomer A (CP2015), Carbomer B (CP2015), Carbomer C (CP2015); Vitamin E TPGS, Film coating premix.
Others: Ethyl Lauroyl Arginate HCL, Octenidine Dihydrochloride, Amino Acid Based Surfactants.